RxDoctor Payments DataLook up a doctor →

Kristina Renfrow

Nurse Practitioner · Lafayette, INNPI 1346765617

Payments from drug & device makers

$8,853in general payments, 2019–2025

Across 523 payments — averaging $16.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Biogen$585
  • Lilly USA, LLC$442
  • Pfizer$421
  • Jazz Pharmaceuticals Inc.$398
  • Lundbeck LLC$382
  • plus $5K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie114$1,265
Biogen27$585
Lilly USA, LLC26$442
Pfizer26$421
Jazz Pharmaceuticals Inc.16$398
Lundbeck LLC23$382
SK Life Science, Inc.10$266
Amneal Pharmaceuticals LLC12$262
Amgen(2 entities)13$258
Takeda Pharmaceuticals U.S.A., Inc.12$252
UCB, Inc.13$247
Novartis12$232
Livanova USA, Inc.8$229
Eisai Inc.12$229
MDD US Operations, LLC19$218
Argenx US, Inc.10$216
Neurocrine Biosciences, Inc.10$207
Teva Pharmaceuticals USA, Inc.9$166
Biohaven Pharmaceutical Holding Company Ltd.15$161
Biohaven Pharmaceuticals, Inc.21$160
Bristol Myers Squibb7$151
CSL Behring7$141
Johnson & Johnson7$135
Harmony Biosciences LLC4$135
Neurelis, Inc.4$110
Axsome Therapeutics, Inc.6$106
Catalyst Pharmaceuticals, Inc.5$104
Otsuka America Pharmaceutical, Inc.5$86
Acadia Pharmaceuticals Inc5$83
AstraZeneca4$82
Banner Life Sciences, LLC4$80
Azurity Pharmaceuticals, Inc.4$72
Scilex Pharmaceuticals Inc.3$67
Aucta Pharmaceuticals, Inc.3$58
Avadel CNS Pharmaceuticals, LLC2$55
Sunovion Pharmaceuticals Inc.4$52
Boston Scientific3$51
Acorda Therapeutics, Inc4$50
EMD Serono, Inc.3$49
Arbor Pharmaceuticals, Inc.2$44
Inspire Medical Systems, Inc.2$43
Impel Pharmaceuticals Inc.2$43
Adamas Pharmaceuticals, Inc.3$42
Alnylam Pharmaceuticals Inc.2$36
Genentech USA, Inc.2$34
Cycle Pharmaceuticals Inc1$29
Almatica Pharma LLC1$26
Averitas Pharma Inc.1$24
Sumitomo Pharma America, Inc.1$24
Mallinckrodt Hospital Products Inc.1$23
E.r. Squibb & Sons, L.L.C.1$23
Tanabe Pharma America, Inc.1$21
Sanofi1$20
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$20
Cala Health, Inc.1$19
Avion Pharmaceuticals1$18
Merz Pharmaceuticals, LLC1$18
Biocodex, Inc.1$16
Kyowa Kirin, Inc.1$15
Idorsia Pharmaceuticals US Inc1$15

How this compares

$8,853 in reported general payments places this provider in the 95th percentile of 2,724 nurse practitioner providers in Indiana.

See all nurse practitioner providers in Indiana

Medicare billing

Part B allowed, 2024
$33,993
Medicare patients
240
Services billed
575

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Lafayette

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →